Study finds 1 in 3 Americans without heart disease miss new cholesterol goals—and 3 in 4 go untreated

A caller survey by investigators from Mass General Brigham finds that astir 1 successful 3 U.S. adults without bosom disease—and astir 4 successful 5 of those who person already had a bosom attack, changeable oregon different cardiovascular event—have LDL, oregon "bad," cholesterin levels supra the goals acceptable by the recently released 2026 American cholesterin guidelines. Additionally, among adults without bosom illness who were supra target, astir 3 successful 4 are not receiving immoderate cholesterol-lowering medication. The results are published successful JAMA.